Emicizumab in Hemophilia A

Tyler W. Buckner; Crystal Watson; Michael Recht

doi:10.1056/NEJMc1916299

Emicizumab in Hemophilia A

Tyler W. Buckner
, Crystal Watson
, Michael Recht

Pediatrics

Research output: Contribution to journal › Letter › peer-review

4 Citations (SciVal)

Original language	English (US)
Pages (from-to)	785-786
Number of pages	2
Journal	The New England journal of medicine
Volume	382
Issue number	8
DOIs	https://doi.org/10.1056/NEJMc1916299
State	Published - Feb 20 2020

Funding

We acknowledge the Genome facility of the Genetics Department (Pieter van der Vlies and others). This work was supported by grants from the Abel Tasman Talent Program, University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313).

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1916299

Cite this

@article{6f280da0da65457facf2bafe4ac098a8,

title = "Emicizumab in Hemophilia A",

author = "Buckner, \{Tyler W.\} and Crystal Watson and Michael Recht",

note = "Funding Information: We acknowledge the Genome facility of the Genetics Department (Pieter van der Vlies and others). This work was supported by grants from the Abel Tasman Talent Program, University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313).",

year = "2020",

month = feb,

day = "20",

doi = "10.1056/NEJMc1916299",

language = "English (US)",

volume = "382",

pages = "785--786",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "8",

}

TY - JOUR

T1 - Emicizumab in Hemophilia A

AU - Buckner, Tyler W.

AU - Watson, Crystal

AU - Recht, Michael

N1 - Funding Information: We acknowledge the Genome facility of the Genetics Department (Pieter van der Vlies and others). This work was supported by grants from the Abel Tasman Talent Program, University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313).

PY - 2020/2/20

Y1 - 2020/2/20

UR - https://www.scopus.com/pages/publications/85079773168

UR - https://www.scopus.com/pages/publications/85079773168#tab=citedBy

U2 - 10.1056/NEJMc1916299

DO - 10.1056/NEJMc1916299

M3 - Letter

C2 - 32074441

AN - SCOPUS:85079773168

SN - 0028-4793

VL - 382

SP - 785

EP - 786

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 8

ER -

Emicizumab in Hemophilia A

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this